Company: ACTG
Filing Date: 2025-05-09
Form Type: 10-Q
Source: 0000934549-25-000021
Chunk: 69

Company: ACACIA RESEARCH CORP
Filing Date: 2025-05-09
Form: 10-Q
Item: Part I, Item 1
Chunk 69
---
 the Plans.The following table summarizes stock option activity for the Plans:OptionsWeighted Average Exercise PriceAggregate Intrinsic ValueWeightedAverageRemaining Contractual Life(In thousands)Outstanding at December 31, 20241,001,520 $4.16 $437 7.3 yearsGranted— $— $— Exercised— $— $— Forfeited/Expired— $— $— Outstanding at March 31, 20251,001,520 $4.16 $— 7.1 yearsExercisable at March 31, 2025842,541 $4.19 $— 7.0 yearsVested and expected to vest at March 31, 20251,001,520 $4.16 $— 7.1 yearsUnrecognized stock-based compensation expense at March 31, 2025 (in thousands)$191 Weighted average remaining vesting period at March 31, 20251.0 yearsDuring the three months ended March 31, 2025, there were no stock options granted. The aggregate fair value of options vested during the three months ended March 31, 2025 and 2024 was $420,000 and $420,000, respectively.The following table summarizes nonvested restricted stock activity for the Plans:RSAsRSUsPSUsSharesWeighted Average Grant Date Fair ValueUnitsWeighted Average Grant Date Fair ValueUnitsWeighted Average Grant Date Fair ValueNonvested at December 31, 202467,668 $3.63 833,195 $4.42 1,981,464 $4.61 Granted— $— — $— — $— Vested(67,668)$3.63 (244,629)$3.97 — $— Forfeited— $— — $— — $— Nonvested at March 31, 2025— $— 588,566 $4.61 1,981,464 $4.61 Unrecognized stock-based compensation expense at March 31, 2025 (in thousands)$— $1,575 $1,052 Weighted average remaining vesting period at March 31, 2025zero years1.0 year1.2 years

34

RSAs and RSUs